The United States Supreme Court is at a standstill as it reviews a case that pits pharmaceutical companies against each other over ownership of the world’s best-selling multiple sclerosis drug, an Associated Press article reported on October 15.

Israel-based Teva Pharmaceutical Industries, Ltd., which distributes $4 billion annually of the drug known as Copaxone, presented its arguments on October 15. According to Teva, the U.S. Court of Appeals for the Federal Circuit made a mistake when it overturned five of its patents for Copaxone. The current point of contention is the issue of whether the appeals court has the capacity to go against factual findings made by a federal district court that earlier approved the patents.

Our legal team at Gagnon, Peacock & Vereeke, P.C., has ample experience when it comes to providing aggressive legal representation to clients involved in intellectual property cases in Dallas, Fort Worth or other areas in Texas. Call our offices today at (214) 824-1414 to set up an appointment.